An exploratory study to evaluate the efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases.
Phase of Trial: Phase IV
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Bilastine (Primary)
- Indications Pruritus; Urticaria
- Focus Therapeutic Use
- Sponsors FAES Farma
- 11 Apr 2017 Status changed from recruiting to completed.
- 03 Aug 2016 New trial record